{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 8,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 1
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 1
      },
      "4": {
        "core": 1,
        "branch": 1
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A11 → (¬(A9 ∨ G) → ¬A10))",
        "prover9_expression": "(fast_track(legislation_delta, drug_x) -> (-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha)))",
        "natural": "Provided that Legislation Delta grants fast track status to Drug X, if it is not the case that Drug X is authorized for emergency use in Region Alpha or Drug X meets the standards of Organization Gamma, then Drug X does not have standard approval in Region Alpha."
      },
      {
        "id": "Rule2",
        "formal": "(A12 → (¬(A9 ∨ G) → ¬A10))",
        "prover9_expression": "(priority_review(legislation_delta, drug_x) -> (-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha)))",
        "natural": "In the event that Legislation Delta grants priority review to Drug X, if neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X lacks standard approval in Region Alpha."
      },
      {
        "id": "Rule3",
        "formal": "(A13 → A11)",
        "prover9_expression": "(breakthrough_designation(legislation_delta, drug_x) -> fast_track(legislation_delta, drug_x))",
        "natural": "Whenever Legislation Delta grants breakthrough designation to Drug X, it follows that Legislation Delta grants fast track status to Drug X."
      },
      {
        "id": "Rule4",
        "formal": "(A14 → A12)",
        "prover9_expression": "(accelerated_approval(legislation_delta, drug_x) -> priority_review(legislation_delta, drug_x))",
        "natural": "Should Legislation Delta grant accelerated approval to Drug X, then Legislation Delta grants priority review to Drug X."
      },
      {
        "id": "Rule5",
        "formal": "(A15 ∨ (A13 ∨ A14))",
        "prover9_expression": "(traditional_pathway(legislation_delta, drug_x) | (breakthrough_designation(legislation_delta, drug_x) | accelerated_approval(legislation_delta, drug_x)))",
        "natural": "Either Legislation Delta follows the traditional pathway for Drug X, or Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X."
      },
      {
        "id": "Rule6",
        "formal": "(A19 → A20)",
        "prover9_expression": "(production_certified(organization_gamma, drug_x) -> quality_approved(organization_gamma, drug_x))",
        "natural": "Given that Organization Gamma has production certification for Drug X, Organization Gamma also has quality approval for Drug X."
      },
      {
        "id": "Rule7",
        "formal": "(A2 → (¬G → ¬A1))",
        "prover9_expression": "(banned(drug_x, region_beta) -> (-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)))",
        "natural": "Assuming Drug X is banned in Region Beta, if Drug X does not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha."
      },
      {
        "id": "Rule8",
        "formal": "(A20 → A18)",
        "prover9_expression": "(quality_approved(organization_gamma, drug_x) -> manufacturing_approved(organization_gamma, drug_x))",
        "natural": "Provided that Organization Gamma has quality approval for Drug X, Organization Gamma has manufacturing approval for Drug X."
      },
      {
        "id": "Rule9",
        "formal": "(A22 → (¬(A4 → (A3 → G)) → ¬A21))",
        "prover9_expression": "(special_exemption(legislation_delta, drug_x) -> (-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x)))",
        "natural": "In the case that Legislation Delta grants a special exemption for Drug X, if it is not true that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X."
      },
      {
        "id": "Rule10",
        "formal": "(A23 → (¬(A4 → (A3 → G)) → ¬A21))",
        "prover9_expression": "(exceptional_approval(legislation_delta, drug_x) -> (-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x)))",
        "natural": "Whenever Legislation Delta grants exceptional approval for Drug X, if the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards is false, then Legislation Delta does not grant a regulatory waiver for Drug X."
      },
      {
        "id": "Rule11",
        "formal": "(A25 → A24)",
        "prover9_expression": "(normal_process(legislation_delta, drug_x) -> standard_procedure(legislation_delta, drug_x))",
        "natural": "If Legislation Delta follows the normal process for Drug X, then Legislation Delta follows standard procedure for Drug X."
      },
      {
        "id": "Rule12",
        "formal": "(A27 → A26)",
        "prover9_expression": "(interim_approval(drug_x, region_alpha) -> preliminary_approval(drug_x, region_alpha))",
        "natural": "Provided that Drug X has interim approval in Region Alpha, Drug X has preliminary approval in Region Alpha."
      },
      {
        "id": "Rule13",
        "formal": "(A28 → A27)",
        "prover9_expression": "(provisional_approval(drug_x, region_alpha) -> interim_approval(drug_x, region_alpha))",
        "natural": "In the event that Drug X has provisional approval in Region Alpha, Drug X has interim approval in Region Alpha."
      },
      {
        "id": "Rule14",
        "formal": "(A31 → A32)",
        "prover9_expression": "(conflicting_status(drug_x, region_alpha) -> approved_status(drug_x, region_alpha))",
        "natural": "If Drug X has conflicting status in Region Alpha, then Drug X has approved status in Region Alpha."
      },
      {
        "id": "Rule15",
        "formal": "(A31 ∨ (A30 → A16))",
        "prover9_expression": "(conflicting_status(drug_x, region_alpha) | (temporary_approval(drug_x, region_alpha) -> conditional_approval(drug_x, region_alpha)))",
        "natural": "Either Drug X has conflicting status in Region Alpha, or if Drug X has temporary approval in Region Alpha, then Drug X has conditional approval in Region Alpha."
      },
      {
        "id": "Rule16",
        "formal": "(A6 → A7)",
        "prover9_expression": "(clinical_trial(drug_x, organization_gamma) -> safety_approved(drug_x, organization_gamma))",
        "natural": "In the case that Drug X is in clinical trial with Organization Gamma, Drug X is safety-approved by Organization Gamma."
      },
      {
        "id": "Rule17",
        "formal": "(A7 → A8)",
        "prover9_expression": "(safety_approved(drug_x, organization_gamma) -> efficacy_approved(drug_x, organization_gamma))",
        "natural": "Should Drug X be safety-approved by Organization Gamma, then Drug X is efficacy-approved by Organization Gamma."
      },
      {
        "id": "Rule18",
        "formal": "(A8 → ¬A5)",
        "prover9_expression": "(efficacy_approved(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
        "natural": "Given that Drug X is efficacy-approved by Organization Gamma, Drug X does not have market access in Region Alpha."
      },
      {
        "id": "Rule19",
        "formal": "(¬(A22 ∨ A23) → A25)",
        "prover9_expression": "(-(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x)) -> normal_process(legislation_delta, drug_x))",
        "natural": "Provided that neither a special exemption nor exceptional approval is granted by Legislation Delta for Drug X, Legislation Delta follows the normal process for Drug X."
      },
      {
        "id": "Rule20",
        "formal": "(¬(A31 → ¬A32) → A33)",
        "prover9_expression": "(-(conflicting_status(drug_x, region_alpha) -> -approved_status(drug_x, region_alpha)) -> resolved_status(drug_x, region_alpha))",
        "natural": "In the event that it is not true that conflicting status of Drug X in Region Alpha implies no approved status, then Drug X has resolved status in Region Alpha."
      },
      {
        "id": "Rule21",
        "formal": "(¬(A4 → (A3 → G)) → A21)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> regulatory_waiver(legislation_delta, drug_x))",
        "natural": "Should the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards be false, then Legislation Delta grants a regulatory waiver for Drug X."
      },
      {
        "id": "Rule22",
        "formal": "(¬(A4 → (A3 → G)) → A5)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> market_access(drug_x, region_alpha))",
        "natural": "If it is not the case that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Drug X has market access in Region Alpha."
      },
      {
        "id": "Rule23",
        "formal": "(¬(A4 → (A3 → G)) → A6)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> clinical_trial(drug_x, organization_gamma))",
        "natural": "Provided that the implication from compliance of Organization Gamma with Legislation Delta to testing resulting in Drug X meeting standards is false, Drug X is in clinical trial with Organization Gamma."
      },
      {
        "id": "Rule24",
        "formal": "(¬(A9 ∨ G) → A10)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> standard_approval(drug_x, region_alpha))",
        "natural": "If neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X has standard approval in Region Alpha."
      },
      {
        "id": "Rule25",
        "formal": "(¬(A9 ∨ G) → ¬A26)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -preliminary_approval(drug_x, region_alpha))",
        "natural": "If it is not the case that Drug X is authorized for emergency use in Region Alpha or meets the standards of Organization Gamma, then Drug X does not have preliminary approval in Region Alpha."
      },
      {
        "id": "Rule26",
        "formal": "(¬(¬(A9 ∨ G) → A28) → A29)",
        "prover9_expression": "(-(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> provisional_approval(drug_x, region_alpha)) -> final_approval(drug_x, region_alpha))",
        "natural": "Provided that the failure of lacking emergency use authorization or meeting standards to imply provisional approval holds, then Drug X has final approval in Region Alpha."
      },
      {
        "id": "Rule27",
        "formal": "(¬(¬G → A16) → A17)",
        "prover9_expression": "(-(-meets_standards(drug_x, organization_gamma) -> conditional_approval(drug_x, region_alpha)) -> full_approval(drug_x, region_alpha))",
        "natural": "In the case that the condition of not meeting standards not implying conditional approval is met, then Drug X has full approval in Region Alpha."
      },
      {
        "id": "Rule28",
        "formal": "(¬(¬G → ¬A1) → A19)",
        "prover9_expression": "(-(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)) -> production_certified(organization_gamma, drug_x))",
        "natural": "If it is not true that not meeting the standards implies no approval for Drug X, then Organization Gamma has production certification for Drug X."
      },
      {
        "id": "Rule29",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-meets_standards(drug_x, organization_gamma) -> approved(drug_x, region_alpha))",
        "natural": "Whenever Drug X does not meet the standards of Organization Gamma, Drug X is approved in Region Alpha."
      },
      {
        "id": "Rule30",
        "formal": "(¬G → A30)",
        "prover9_expression": "(-meets_standards(drug_x, organization_gamma) -> temporary_approval(drug_x, region_alpha))",
        "natural": "In the event that Drug X does not meet the standards of Organization Gamma, Drug X has temporary approval in Region Alpha."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A2",
        "prover9_expression": "banned(drug_x, region_beta)",
        "natural": "Drug X is banned in Region Beta."
      },
      {
        "id": "Fact2",
        "formal": "A3",
        "prover9_expression": "tested(drug_x, organization_gamma)",
        "natural": "Drug X is tested by Organization Gamma."
      },
      {
        "id": "Fact3",
        "formal": "A4",
        "prover9_expression": "compliant(organization_gamma, legislation_delta)",
        "natural": "Organization Gamma is compliant with Legislation Delta."
      },
      {
        "id": "Fact4",
        "formal": "¬A15",
        "prover9_expression": "-traditional_pathway(legislation_delta, drug_x)",
        "natural": "It is not the case that Legislation Delta follows the traditional pathway for Drug X."
      },
      {
        "id": "Fact5",
        "formal": "¬A16",
        "prover9_expression": "-conditional_approval(drug_x, region_alpha)",
        "natural": "Drug X does not have conditional approval in Region Alpha."
      },
      {
        "id": "Fact6",
        "formal": "¬A17",
        "prover9_expression": "-full_approval(drug_x, region_alpha)",
        "natural": "Drug X does not have full approval in Region Alpha."
      },
      {
        "id": "Fact7",
        "formal": "¬A18",
        "prover9_expression": "-manufacturing_approved(organization_gamma, drug_x)",
        "natural": "Organization Gamma does not have manufacturing approval for Drug X."
      },
      {
        "id": "Fact8",
        "formal": "¬A24",
        "prover9_expression": "-standard_procedure(legislation_delta, drug_x)",
        "natural": "Legislation Delta does not follow standard procedure for Drug X."
      },
      {
        "id": "Fact9",
        "formal": "¬A29",
        "prover9_expression": "-final_approval(drug_x, region_alpha)",
        "natural": "Drug X does not have final approval in Region Alpha."
      },
      {
        "id": "Fact10",
        "formal": "¬A33",
        "prover9_expression": "-resolved_status(drug_x, region_alpha)",
        "natural": "Drug X does not have resolved status in Region Alpha."
      },
      {
        "id": "Fact11",
        "formal": "¬A9",
        "prover9_expression": "-emergency_use(drug_x, region_alpha)",
        "natural": "Drug X is not authorized for emergency use in Region Alpha."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "meets_standards(drug_x, organization_gamma)",
    "natural": "Drug X meets the standards of Organization Gamma."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> (-G -> -A1))",
            "A2"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Should Drug X not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A7 -> A8)",
            "(A8 -> -A5)"
          ],
          "conclusion": "(A7 -> -A5)",
          "natural": "If Drug X is safety-approved by Organization Gamma, then Drug X lacks market access in Region Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A6 -> A7)",
            "(A7 -> -A5)"
          ],
          "conclusion": "(A6 -> -A5)",
          "natural": "Provided that Drug X is in clinical trial with Organization Gamma, Drug X does not have market access in Region Alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A4 -> (A3 -> G)) -> A6)",
            "(A6 -> -A5)"
          ],
          "conclusion": "(-(A4 -> (A3 -> G)) -> -A5)",
          "natural": "Whenever the condition that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards is false, Drug X does not have market access in Region Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A4 -> (A3 -> G)) -> A5)",
            "(-(A4 -> (A3 -> G)) -> -A5)"
          ],
          "conclusion": "(A4 -> (A3 -> G))",
          "natural": "Whenever Organization Gamma is compliant with Legislation Delta, if Drug X is tested by Organization Gamma, then Drug X meets the standards of Organization Gamma."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A4 -> (A3 -> G))",
            "A4"
          ],
          "conclusion": "(A3 -> G)",
          "natural": "Should Drug X be tested by Organization Gamma, then Drug X meets the standards of Organization Gamma."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A3 -> G)",
            "A3"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A15 | (A13 | A14))",
            "-A15"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A13 -> A11)",
            "(A14 -> A12)",
            "(A13 | A14)"
          ],
          "conclusion": "(A11 | A12)",
          "natural": "Either Legislation Delta grants fast track status to Drug X, or Legislation Delta grants priority review to Drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A11 | A12)",
            "(A11 -> (-(A9 | G) -> -A10))",
            "(A12 -> (-(A9 | G) -> -A10))"
          ],
          "conclusion": "(-(A9 | G) -> -A10)",
          "natural": "Given that Drug X is not authorized for emergency use in Region Alpha and does not meet the standards of Organization Gamma, Drug X does not have standard approval in Region Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 | G) -> A10)",
            "(-(A9 | G) -> -A10)"
          ],
          "conclusion": "(A9 | G)",
          "natural": "Either Drug X is authorized for emergency use in Region Alpha, or Drug X meets the standards of Organization Gamma."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A9 | G)",
            "-A9"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-G -> A16) -> A17)",
            "-A17"
          ],
          "conclusion": "(-G -> A16)",
          "natural": "Provided that Drug X does not meet the standards of Organization Gamma, Drug X has conditional approval in Region Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A16)",
            "-A16"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A19 -> A20)",
            "(A20 -> A18)"
          ],
          "conclusion": "(A19 -> A18)",
          "natural": "If Organization Gamma has production certification for Drug X, then Organization Gamma has manufacturing approval for Drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-G -> -A1) -> A19)",
            "(A19 -> A18)"
          ],
          "conclusion": "(-(-G -> -A1) -> A18)",
          "natural": "Should the scenario where not meeting standards does not lead to lack of approval occur, then Organization Gamma has manufacturing approval for Drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-G -> -A1) -> A18)",
            "-A18"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Should Drug X not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A22 | A23) -> A25)",
            "(A25 -> A24)"
          ],
          "conclusion": "(-(A22 | A23) -> A24)",
          "natural": "If it is not the case that Legislation Delta grants a special exemption for Drug X or exceptional approval for Drug X, then Legislation Delta follows standard procedure for Drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A22 | A23) -> A24)",
            "-A24"
          ],
          "conclusion": "(A22 | A23)",
          "natural": "Either Legislation Delta grants a special exemption for Drug X, or Legislation Delta grants exceptional approval for Drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A22 | A23)",
            "(A22 -> (-(A4 -> (A3 -> G)) -> -A21))",
            "(A23 -> (-(A4 -> (A3 -> G)) -> -A21))"
          ],
          "conclusion": "(-(A4 -> (A3 -> G)) -> -A21)",
          "natural": "In the case that it is not true that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A4 -> (A3 -> G)) -> A21)",
            "(-(A4 -> (A3 -> G)) -> -A21)"
          ],
          "conclusion": "(A4 -> (A3 -> G))",
          "natural": "Whenever Organization Gamma is compliant with Legislation Delta, if Drug X is tested by Organization Gamma, then Drug X meets the standards of Organization Gamma."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A4 -> (A3 -> G))",
            "A4"
          ],
          "conclusion": "(A3 -> G)",
          "natural": "Should Drug X be tested by Organization Gamma, then Drug X meets the standards of Organization Gamma."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A3 -> G)",
            "A3"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A9 | G) -> A28) -> A29)",
            "-A29"
          ],
          "conclusion": "(-(A9 | G) -> A28)",
          "natural": "Should Drug X not be authorized for emergency use in Region Alpha and not meet the standards of Organization Gamma, then Drug X has provisional approval in Region Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 | G) -> A28)",
            "(A28 -> A27)"
          ],
          "conclusion": "(-(A9 | G) -> A27)",
          "natural": "In the event that Drug X lacks emergency use authorization in Region Alpha and fails to meet the standards of Organization Gamma, Drug X has interim approval in Region Alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 | G) -> A27)",
            "(A27 -> A26)"
          ],
          "conclusion": "(-(A9 | G) -> A26)",
          "natural": "Provided that Drug X is not authorized for emergency use in Region Alpha and does not meet the standards of Organization Gamma, Drug X has preliminary approval in Region Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 | G) -> A26)",
            "(-(A9 | G) -> -A26)"
          ],
          "conclusion": "(A9 | G)",
          "natural": "Either Drug X is authorized for emergency use in Region Alpha, or Drug X meets the standards of Organization Gamma."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A9 | G)",
            "-A9"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A31 -> -A32) -> A33)",
            "-A33"
          ],
          "conclusion": "(A31 -> -A32)",
          "natural": "Provided that Drug X has conflicting status in Region Alpha, Drug X does not have approved status in Region Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(A31 -> A32)",
            "(A31 -> -A32)"
          ],
          "conclusion": "-A31",
          "natural": "Drug X does not have conflicting status in Region Alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A31 | (A30 -> A16))",
            "-A31"
          ],
          "conclusion": "(A30 -> A16)",
          "natural": "Given that Drug X has temporary approval in Region Alpha, Drug X has conditional approval in Region Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A30)",
            "(A30 -> A16)"
          ],
          "conclusion": "(-G -> A16)",
          "natural": "Provided that Drug X does not meet the standards of Organization Gamma, Drug X has conditional approval in Region Alpha."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A16)",
            "-A16"
          ],
          "conclusion": "G",
          "natural": "Drug X meets the standards of Organization Gamma."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Regulation",
    "atomic_facts": {
      "A1": "approved(drug_x, region_alpha)",
      "A2": "banned(drug_x, region_beta)",
      "A3": "tested(drug_x, organization_gamma)",
      "A4": "compliant(organization_gamma, legislation_delta)",
      "A5": "market_access(drug_x, region_alpha)",
      "A6": "clinical_trial(drug_x, organization_gamma)",
      "A7": "safety_approved(drug_x, organization_gamma)",
      "A8": "efficacy_approved(drug_x, organization_gamma)",
      "A9": "emergency_use(drug_x, region_alpha)",
      "A10": "standard_approval(drug_x, region_alpha)",
      "A11": "fast_track(legislation_delta, drug_x)",
      "A12": "priority_review(legislation_delta, drug_x)",
      "A13": "breakthrough_designation(legislation_delta, drug_x)",
      "A14": "accelerated_approval(legislation_delta, drug_x)",
      "A15": "traditional_pathway(legislation_delta, drug_x)",
      "A16": "conditional_approval(drug_x, region_alpha)",
      "A17": "full_approval(drug_x, region_alpha)",
      "A18": "manufacturing_approved(organization_gamma, drug_x)",
      "A19": "production_certified(organization_gamma, drug_x)",
      "A20": "quality_approved(organization_gamma, drug_x)",
      "A21": "regulatory_waiver(legislation_delta, drug_x)",
      "A22": "special_exemption(legislation_delta, drug_x)",
      "A23": "exceptional_approval(legislation_delta, drug_x)",
      "A24": "standard_procedure(legislation_delta, drug_x)",
      "A25": "normal_process(legislation_delta, drug_x)",
      "A26": "preliminary_approval(drug_x, region_alpha)",
      "A27": "interim_approval(drug_x, region_alpha)",
      "A28": "provisional_approval(drug_x, region_alpha)",
      "A29": "final_approval(drug_x, region_alpha)",
      "A30": "temporary_approval(drug_x, region_alpha)",
      "A31": "conflicting_status(drug_x, region_alpha)",
      "A32": "approved_status(drug_x, region_alpha)",
      "A33": "resolved_status(drug_x, region_alpha)",
      "G": "meets_standards(drug_x, organization_gamma)"
    },
    "natural_facts": {
      "A1": "Drug X is approved in Region Alpha.",
      "A2": "Drug X is banned in Region Beta.",
      "A3": "Drug X is tested by Organization Gamma.",
      "A4": "Organization Gamma is compliant with Legislation Delta.",
      "A5": "Drug X has market access in Region Alpha.",
      "A6": "Drug X is in clinical trial with Organization Gamma.",
      "A7": "Drug X is safety-approved by Organization Gamma.",
      "A8": "Drug X is efficacy-approved by Organization Gamma.",
      "A9": "Drug X is authorized for emergency use in Region Alpha.",
      "A10": "Drug X has standard approval in Region Alpha.",
      "A11": "Legislation Delta grants fast track status to Drug X.",
      "A12": "Legislation Delta grants priority review to Drug X.",
      "A13": "Legislation Delta grants breakthrough designation to Drug X.",
      "A14": "Legislation Delta grants accelerated approval to Drug X.",
      "A15": "Legislation Delta follows the traditional pathway for Drug X.",
      "A16": "Drug X has conditional approval in Region Alpha.",
      "A17": "Drug X has full approval in Region Alpha.",
      "A18": "Organization Gamma has manufacturing approval for Drug X.",
      "A19": "Organization Gamma has production certification for Drug X.",
      "A20": "Organization Gamma has quality approval for Drug X.",
      "A21": "Legislation Delta grants a regulatory waiver for Drug X.",
      "A22": "Legislation Delta grants a special exemption for Drug X.",
      "A23": "Legislation Delta grants exceptional approval for Drug X.",
      "A24": "Legislation Delta follows standard procedure for Drug X.",
      "A25": "Legislation Delta follows the normal process for Drug X.",
      "A26": "Drug X has preliminary approval in Region Alpha.",
      "A27": "Drug X has interim approval in Region Alpha.",
      "A28": "Drug X has provisional approval in Region Alpha.",
      "A29": "Drug X has final approval in Region Alpha.",
      "A30": "Drug X has temporary approval in Region Alpha.",
      "A31": "Drug X has conflicting status in Region Alpha.",
      "A32": "Drug X has approved status in Region Alpha.",
      "A33": "Drug X has resolved status in Region Alpha.",
      "G": "Drug X meets the standards of Organization Gamma."
    },
    "prover9_expressions": [
      "(fast_track(legislation_delta, drug_x) -> (-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha)))",
      "(fast_track(legislation_delta, drug_x) | priority_review(legislation_delta, drug_x))",
      "(priority_review(legislation_delta, drug_x) -> (-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha)))",
      "(breakthrough_designation(legislation_delta, drug_x) -> fast_track(legislation_delta, drug_x))",
      "(breakthrough_designation(legislation_delta, drug_x) | accelerated_approval(legislation_delta, drug_x))",
      "(accelerated_approval(legislation_delta, drug_x) -> priority_review(legislation_delta, drug_x))",
      "(traditional_pathway(legislation_delta, drug_x) | (breakthrough_designation(legislation_delta, drug_x) | accelerated_approval(legislation_delta, drug_x)))",
      "(production_certified(organization_gamma, drug_x) -> manufacturing_approved(organization_gamma, drug_x))",
      "(production_certified(organization_gamma, drug_x) -> quality_approved(organization_gamma, drug_x))",
      "(banned(drug_x, region_beta) -> (-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)))",
      "(quality_approved(organization_gamma, drug_x) -> manufacturing_approved(organization_gamma, drug_x))",
      "(special_exemption(legislation_delta, drug_x) -> (-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x)))",
      "(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x))",
      "(exceptional_approval(legislation_delta, drug_x) -> (-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x)))",
      "(normal_process(legislation_delta, drug_x) -> standard_procedure(legislation_delta, drug_x))",
      "(interim_approval(drug_x, region_alpha) -> preliminary_approval(drug_x, region_alpha))",
      "(provisional_approval(drug_x, region_alpha) -> interim_approval(drug_x, region_alpha))",
      "(tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))",
      "(temporary_approval(drug_x, region_alpha) -> conditional_approval(drug_x, region_alpha))",
      "(conflicting_status(drug_x, region_alpha) -> approved_status(drug_x, region_alpha))",
      "(conflicting_status(drug_x, region_alpha) -> -approved_status(drug_x, region_alpha))",
      "(conflicting_status(drug_x, region_alpha) | (temporary_approval(drug_x, region_alpha) -> conditional_approval(drug_x, region_alpha)))",
      "(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma)))",
      "(clinical_trial(drug_x, organization_gamma) -> safety_approved(drug_x, organization_gamma))",
      "(clinical_trial(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
      "(safety_approved(drug_x, organization_gamma) -> efficacy_approved(drug_x, organization_gamma))",
      "(safety_approved(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
      "(efficacy_approved(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
      "(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma))",
      "(-(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x)) -> standard_procedure(legislation_delta, drug_x))",
      "(-(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x)) -> normal_process(legislation_delta, drug_x))",
      "(-(conflicting_status(drug_x, region_alpha) -> -approved_status(drug_x, region_alpha)) -> resolved_status(drug_x, region_alpha))",
      "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> regulatory_waiver(legislation_delta, drug_x))",
      "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> market_access(drug_x, region_alpha))",
      "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> clinical_trial(drug_x, organization_gamma))",
      "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x))",
      "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -market_access(drug_x, region_alpha))",
      "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> standard_approval(drug_x, region_alpha))",
      "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> preliminary_approval(drug_x, region_alpha))",
      "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> interim_approval(drug_x, region_alpha))",
      "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> provisional_approval(drug_x, region_alpha))",
      "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha))",
      "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -preliminary_approval(drug_x, region_alpha))",
      "(-(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> provisional_approval(drug_x, region_alpha)) -> final_approval(drug_x, region_alpha))",
      "(-(-meets_standards(drug_x, organization_gamma) -> conditional_approval(drug_x, region_alpha)) -> full_approval(drug_x, region_alpha))",
      "(-(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)) -> manufacturing_approved(organization_gamma, drug_x))",
      "(-(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)) -> production_certified(organization_gamma, drug_x))",
      "(-meets_standards(drug_x, organization_gamma) -> approved(drug_x, region_alpha))",
      "(-meets_standards(drug_x, organization_gamma) -> conditional_approval(drug_x, region_alpha))",
      "(-meets_standards(drug_x, organization_gamma) -> temporary_approval(drug_x, region_alpha))",
      "(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha))",
      "banned(drug_x, region_beta)",
      "tested(drug_x, organization_gamma)",
      "compliant(organization_gamma, legislation_delta)",
      "meets_standards(drug_x, organization_gamma)",
      "-traditional_pathway(legislation_delta, drug_x)",
      "-conditional_approval(drug_x, region_alpha)",
      "-full_approval(drug_x, region_alpha)",
      "-manufacturing_approved(organization_gamma, drug_x)",
      "-standard_procedure(legislation_delta, drug_x)",
      "-final_approval(drug_x, region_alpha)",
      "-conflicting_status(drug_x, region_alpha)",
      "-resolved_status(drug_x, region_alpha)",
      "-emergency_use(drug_x, region_alpha)"
    ],
    "natural_expressions": [
      "Provided that Legislation Delta grants fast track status to Drug X, if it is not the case that Drug X is authorized for emergency use in Region Alpha or Drug X meets the standards of Organization Gamma, then Drug X does not have standard approval in Region Alpha.",
      "Either Legislation Delta grants fast track status to Drug X, or Legislation Delta grants priority review to Drug X.",
      "In the event that Legislation Delta grants priority review to Drug X, if neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X lacks standard approval in Region Alpha.",
      "Whenever Legislation Delta grants breakthrough designation to Drug X, it follows that Legislation Delta grants fast track status to Drug X.",
      "Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X.",
      "Should Legislation Delta grant accelerated approval to Drug X, then Legislation Delta grants priority review to Drug X.",
      "Either Legislation Delta follows the traditional pathway for Drug X, or Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X.",
      "If Organization Gamma has production certification for Drug X, then Organization Gamma has manufacturing approval for Drug X.",
      "Given that Organization Gamma has production certification for Drug X, Organization Gamma also has quality approval for Drug X.",
      "Assuming Drug X is banned in Region Beta, if Drug X does not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha.",
      "Provided that Organization Gamma has quality approval for Drug X, Organization Gamma has manufacturing approval for Drug X.",
      "In the case that Legislation Delta grants a special exemption for Drug X, if it is not true that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X.",
      "Either Legislation Delta grants a special exemption for Drug X, or Legislation Delta grants exceptional approval for Drug X.",
      "Whenever Legislation Delta grants exceptional approval for Drug X, if the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards is false, then Legislation Delta does not grant a regulatory waiver for Drug X.",
      "If Legislation Delta follows the normal process for Drug X, then Legislation Delta follows standard procedure for Drug X.",
      "Provided that Drug X has interim approval in Region Alpha, Drug X has preliminary approval in Region Alpha.",
      "In the event that Drug X has provisional approval in Region Alpha, Drug X has interim approval in Region Alpha.",
      "Should Drug X be tested by Organization Gamma, then Drug X meets the standards of Organization Gamma.",
      "Given that Drug X has temporary approval in Region Alpha, Drug X has conditional approval in Region Alpha.",
      "If Drug X has conflicting status in Region Alpha, then Drug X has approved status in Region Alpha.",
      "Provided that Drug X has conflicting status in Region Alpha, Drug X does not have approved status in Region Alpha.",
      "Either Drug X has conflicting status in Region Alpha, or if Drug X has temporary approval in Region Alpha, then Drug X has conditional approval in Region Alpha.",
      "Whenever Organization Gamma is compliant with Legislation Delta, if Drug X is tested by Organization Gamma, then Drug X meets the standards of Organization Gamma.",
      "In the case that Drug X is in clinical trial with Organization Gamma, Drug X is safety-approved by Organization Gamma.",
      "Provided that Drug X is in clinical trial with Organization Gamma, Drug X does not have market access in Region Alpha.",
      "Should Drug X be safety-approved by Organization Gamma, then Drug X is efficacy-approved by Organization Gamma.",
      "If Drug X is safety-approved by Organization Gamma, then Drug X lacks market access in Region Alpha.",
      "Given that Drug X is efficacy-approved by Organization Gamma, Drug X does not have market access in Region Alpha.",
      "Either Drug X is authorized for emergency use in Region Alpha, or Drug X meets the standards of Organization Gamma.",
      "If it is not the case that Legislation Delta grants a special exemption for Drug X or exceptional approval for Drug X, then Legislation Delta follows standard procedure for Drug X.",
      "Provided that neither a special exemption nor exceptional approval is granted by Legislation Delta for Drug X, Legislation Delta follows the normal process for Drug X.",
      "In the event that it is not true that conflicting status of Drug X in Region Alpha implies no approved status, then Drug X has resolved status in Region Alpha.",
      "Should the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards be false, then Legislation Delta grants a regulatory waiver for Drug X.",
      "If it is not the case that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Drug X has market access in Region Alpha.",
      "Provided that the implication from compliance of Organization Gamma with Legislation Delta to testing resulting in Drug X meeting standards is false, Drug X is in clinical trial with Organization Gamma.",
      "In the case that it is not true that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X.",
      "Whenever the condition that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards is false, Drug X does not have market access in Region Alpha.",
      "If neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X has standard approval in Region Alpha.",
      "Provided that Drug X is not authorized for emergency use in Region Alpha and does not meet the standards of Organization Gamma, Drug X has preliminary approval in Region Alpha.",
      "In the event that Drug X lacks emergency use authorization in Region Alpha and fails to meet the standards of Organization Gamma, Drug X has interim approval in Region Alpha.",
      "Should Drug X not be authorized for emergency use in Region Alpha and not meet the standards of Organization Gamma, then Drug X has provisional approval in Region Alpha.",
      "Given that Drug X is not authorized for emergency use in Region Alpha and does not meet the standards of Organization Gamma, Drug X does not have standard approval in Region Alpha.",
      "If it is not the case that Drug X is authorized for emergency use in Region Alpha or meets the standards of Organization Gamma, then Drug X does not have preliminary approval in Region Alpha.",
      "Provided that the failure of lacking emergency use authorization or meeting standards to imply provisional approval holds, then Drug X has final approval in Region Alpha.",
      "In the case that the condition of not meeting standards not implying conditional approval is met, then Drug X has full approval in Region Alpha.",
      "Should the scenario where not meeting standards does not lead to lack of approval occur, then Organization Gamma has manufacturing approval for Drug X.",
      "If it is not true that not meeting the standards implies no approval for Drug X, then Organization Gamma has production certification for Drug X.",
      "Whenever Drug X does not meet the standards of Organization Gamma, Drug X is approved in Region Alpha.",
      "Provided that Drug X does not meet the standards of Organization Gamma, Drug X has conditional approval in Region Alpha.",
      "In the event that Drug X does not meet the standards of Organization Gamma, Drug X has temporary approval in Region Alpha.",
      "Should Drug X not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha.",
      "Drug X is banned in Region Beta.",
      "Drug X is tested by Organization Gamma.",
      "Organization Gamma is compliant with Legislation Delta.",
      "Drug X meets the standards of Organization Gamma.",
      "It is not the case that Legislation Delta follows the traditional pathway for Drug X.",
      "Drug X does not have conditional approval in Region Alpha.",
      "Drug X does not have full approval in Region Alpha.",
      "Organization Gamma does not have manufacturing approval for Drug X.",
      "Legislation Delta does not follow standard procedure for Drug X.",
      "Drug X does not have final approval in Region Alpha.",
      "Drug X does not have conflicting status in Region Alpha.",
      "Drug X does not have resolved status in Region Alpha.",
      "Drug X is not authorized for emergency use in Region Alpha."
    ],
    "node_mappings": {
      "(A11 → (¬(A9 ∨ G) → ¬A10))": {
        "formal": "(A11 → (¬(A9 ∨ G) → ¬A10))",
        "prover9": "(A11 -> (-(A9 | G) -> -A10))",
        "prover9_expression": "(fast_track(legislation_delta, drug_x) -> (-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha)))",
        "natural": "Provided that Legislation Delta grants fast track status to Drug X, if it is not the case that Drug X is authorized for emergency use in Region Alpha or Drug X meets the standards of Organization Gamma, then Drug X does not have standard approval in Region Alpha."
      },
      "(A11 ∨ A12)": {
        "formal": "(A11 ∨ A12)",
        "prover9": "(A11 | A12)",
        "prover9_expression": "(fast_track(legislation_delta, drug_x) | priority_review(legislation_delta, drug_x))",
        "natural": "Either Legislation Delta grants fast track status to Drug X, or Legislation Delta grants priority review to Drug X."
      },
      "(A12 → (¬(A9 ∨ G) → ¬A10))": {
        "formal": "(A12 → (¬(A9 ∨ G) → ¬A10))",
        "prover9": "(A12 -> (-(A9 | G) -> -A10))",
        "prover9_expression": "(priority_review(legislation_delta, drug_x) -> (-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha)))",
        "natural": "In the event that Legislation Delta grants priority review to Drug X, if neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X lacks standard approval in Region Alpha."
      },
      "(A13 → A11)": {
        "formal": "(A13 → A11)",
        "prover9": "(A13 -> A11)",
        "prover9_expression": "(breakthrough_designation(legislation_delta, drug_x) -> fast_track(legislation_delta, drug_x))",
        "natural": "Whenever Legislation Delta grants breakthrough designation to Drug X, it follows that Legislation Delta grants fast track status to Drug X."
      },
      "(A13 ∨ A14)": {
        "formal": "(A13 ∨ A14)",
        "prover9": "(A13 | A14)",
        "prover9_expression": "(breakthrough_designation(legislation_delta, drug_x) | accelerated_approval(legislation_delta, drug_x))",
        "natural": "Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X."
      },
      "(A14 → A12)": {
        "formal": "(A14 → A12)",
        "prover9": "(A14 -> A12)",
        "prover9_expression": "(accelerated_approval(legislation_delta, drug_x) -> priority_review(legislation_delta, drug_x))",
        "natural": "Should Legislation Delta grant accelerated approval to Drug X, then Legislation Delta grants priority review to Drug X."
      },
      "(A15 ∨ (A13 ∨ A14))": {
        "formal": "(A15 ∨ (A13 ∨ A14))",
        "prover9": "(A15 | (A13 | A14))",
        "prover9_expression": "(traditional_pathway(legislation_delta, drug_x) | (breakthrough_designation(legislation_delta, drug_x) | accelerated_approval(legislation_delta, drug_x)))",
        "natural": "Either Legislation Delta follows the traditional pathway for Drug X, or Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X."
      },
      "(A19 → A18)": {
        "formal": "(A19 → A18)",
        "prover9": "(A19 -> A18)",
        "prover9_expression": "(production_certified(organization_gamma, drug_x) -> manufacturing_approved(organization_gamma, drug_x))",
        "natural": "If Organization Gamma has production certification for Drug X, then Organization Gamma has manufacturing approval for Drug X."
      },
      "(A19 → A20)": {
        "formal": "(A19 → A20)",
        "prover9": "(A19 -> A20)",
        "prover9_expression": "(production_certified(organization_gamma, drug_x) -> quality_approved(organization_gamma, drug_x))",
        "natural": "Given that Organization Gamma has production certification for Drug X, Organization Gamma also has quality approval for Drug X."
      },
      "(A2 → (¬G → ¬A1))": {
        "formal": "(A2 → (¬G → ¬A1))",
        "prover9": "(A2 -> (-G -> -A1))",
        "prover9_expression": "(banned(drug_x, region_beta) -> (-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)))",
        "natural": "Assuming Drug X is banned in Region Beta, if Drug X does not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha."
      },
      "(A20 → A18)": {
        "formal": "(A20 → A18)",
        "prover9": "(A20 -> A18)",
        "prover9_expression": "(quality_approved(organization_gamma, drug_x) -> manufacturing_approved(organization_gamma, drug_x))",
        "natural": "Provided that Organization Gamma has quality approval for Drug X, Organization Gamma has manufacturing approval for Drug X."
      },
      "(A22 → (¬(A4 → (A3 → G)) → ¬A21))": {
        "formal": "(A22 → (¬(A4 → (A3 → G)) → ¬A21))",
        "prover9": "(A22 -> (-(A4 -> (A3 -> G)) -> -A21))",
        "prover9_expression": "(special_exemption(legislation_delta, drug_x) -> (-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x)))",
        "natural": "In the case that Legislation Delta grants a special exemption for Drug X, if it is not true that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X."
      },
      "(A22 ∨ A23)": {
        "formal": "(A22 ∨ A23)",
        "prover9": "(A22 | A23)",
        "prover9_expression": "(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x))",
        "natural": "Either Legislation Delta grants a special exemption for Drug X, or Legislation Delta grants exceptional approval for Drug X."
      },
      "(A23 → (¬(A4 → (A3 → G)) → ¬A21))": {
        "formal": "(A23 → (¬(A4 → (A3 → G)) → ¬A21))",
        "prover9": "(A23 -> (-(A4 -> (A3 -> G)) -> -A21))",
        "prover9_expression": "(exceptional_approval(legislation_delta, drug_x) -> (-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x)))",
        "natural": "Whenever Legislation Delta grants exceptional approval for Drug X, if the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards is false, then Legislation Delta does not grant a regulatory waiver for Drug X."
      },
      "(A25 → A24)": {
        "formal": "(A25 → A24)",
        "prover9": "(A25 -> A24)",
        "prover9_expression": "(normal_process(legislation_delta, drug_x) -> standard_procedure(legislation_delta, drug_x))",
        "natural": "If Legislation Delta follows the normal process for Drug X, then Legislation Delta follows standard procedure for Drug X."
      },
      "(A27 → A26)": {
        "formal": "(A27 → A26)",
        "prover9": "(A27 -> A26)",
        "prover9_expression": "(interim_approval(drug_x, region_alpha) -> preliminary_approval(drug_x, region_alpha))",
        "natural": "Provided that Drug X has interim approval in Region Alpha, Drug X has preliminary approval in Region Alpha."
      },
      "(A28 → A27)": {
        "formal": "(A28 → A27)",
        "prover9": "(A28 -> A27)",
        "prover9_expression": "(provisional_approval(drug_x, region_alpha) -> interim_approval(drug_x, region_alpha))",
        "natural": "In the event that Drug X has provisional approval in Region Alpha, Drug X has interim approval in Region Alpha."
      },
      "(A3 → G)": {
        "formal": "(A3 → G)",
        "prover9": "(A3 -> G)",
        "prover9_expression": "(tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))",
        "natural": "Should Drug X be tested by Organization Gamma, then Drug X meets the standards of Organization Gamma."
      },
      "(A30 → A16)": {
        "formal": "(A30 → A16)",
        "prover9": "(A30 -> A16)",
        "prover9_expression": "(temporary_approval(drug_x, region_alpha) -> conditional_approval(drug_x, region_alpha))",
        "natural": "Given that Drug X has temporary approval in Region Alpha, Drug X has conditional approval in Region Alpha."
      },
      "(A31 → A32)": {
        "formal": "(A31 → A32)",
        "prover9": "(A31 -> A32)",
        "prover9_expression": "(conflicting_status(drug_x, region_alpha) -> approved_status(drug_x, region_alpha))",
        "natural": "If Drug X has conflicting status in Region Alpha, then Drug X has approved status in Region Alpha."
      },
      "(A31 → ¬A32)": {
        "formal": "(A31 → ¬A32)",
        "prover9": "(A31 -> -A32)",
        "prover9_expression": "(conflicting_status(drug_x, region_alpha) -> -approved_status(drug_x, region_alpha))",
        "natural": "Provided that Drug X has conflicting status in Region Alpha, Drug X does not have approved status in Region Alpha."
      },
      "(A31 ∨ (A30 → A16))": {
        "formal": "(A31 ∨ (A30 → A16))",
        "prover9": "(A31 | (A30 -> A16))",
        "prover9_expression": "(conflicting_status(drug_x, region_alpha) | (temporary_approval(drug_x, region_alpha) -> conditional_approval(drug_x, region_alpha)))",
        "natural": "Either Drug X has conflicting status in Region Alpha, or if Drug X has temporary approval in Region Alpha, then Drug X has conditional approval in Region Alpha."
      },
      "(A4 → (A3 → G))": {
        "formal": "(A4 → (A3 → G))",
        "prover9": "(A4 -> (A3 -> G))",
        "prover9_expression": "(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma)))",
        "natural": "Whenever Organization Gamma is compliant with Legislation Delta, if Drug X is tested by Organization Gamma, then Drug X meets the standards of Organization Gamma."
      },
      "(A6 → A7)": {
        "formal": "(A6 → A7)",
        "prover9": "(A6 -> A7)",
        "prover9_expression": "(clinical_trial(drug_x, organization_gamma) -> safety_approved(drug_x, organization_gamma))",
        "natural": "In the case that Drug X is in clinical trial with Organization Gamma, Drug X is safety-approved by Organization Gamma."
      },
      "(A6 → ¬A5)": {
        "formal": "(A6 → ¬A5)",
        "prover9": "(A6 -> -A5)",
        "prover9_expression": "(clinical_trial(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
        "natural": "Provided that Drug X is in clinical trial with Organization Gamma, Drug X does not have market access in Region Alpha."
      },
      "(A7 → A8)": {
        "formal": "(A7 → A8)",
        "prover9": "(A7 -> A8)",
        "prover9_expression": "(safety_approved(drug_x, organization_gamma) -> efficacy_approved(drug_x, organization_gamma))",
        "natural": "Should Drug X be safety-approved by Organization Gamma, then Drug X is efficacy-approved by Organization Gamma."
      },
      "(A7 → ¬A5)": {
        "formal": "(A7 → ¬A5)",
        "prover9": "(A7 -> -A5)",
        "prover9_expression": "(safety_approved(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
        "natural": "If Drug X is safety-approved by Organization Gamma, then Drug X lacks market access in Region Alpha."
      },
      "(A8 → ¬A5)": {
        "formal": "(A8 → ¬A5)",
        "prover9": "(A8 -> -A5)",
        "prover9_expression": "(efficacy_approved(drug_x, organization_gamma) -> -market_access(drug_x, region_alpha))",
        "natural": "Given that Drug X is efficacy-approved by Organization Gamma, Drug X does not have market access in Region Alpha."
      },
      "(A9 ∨ G)": {
        "formal": "(A9 ∨ G)",
        "prover9": "(A9 | G)",
        "prover9_expression": "(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma))",
        "natural": "Either Drug X is authorized for emergency use in Region Alpha, or Drug X meets the standards of Organization Gamma."
      },
      "(¬(A22 ∨ A23) → A24)": {
        "formal": "(¬(A22 ∨ A23) → A24)",
        "prover9": "(-(A22 | A23) -> A24)",
        "prover9_expression": "(-(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x)) -> standard_procedure(legislation_delta, drug_x))",
        "natural": "If it is not the case that Legislation Delta grants a special exemption for Drug X or exceptional approval for Drug X, then Legislation Delta follows standard procedure for Drug X."
      },
      "(¬(A22 ∨ A23) → A25)": {
        "formal": "(¬(A22 ∨ A23) → A25)",
        "prover9": "(-(A22 | A23) -> A25)",
        "prover9_expression": "(-(special_exemption(legislation_delta, drug_x) | exceptional_approval(legislation_delta, drug_x)) -> normal_process(legislation_delta, drug_x))",
        "natural": "Provided that neither a special exemption nor exceptional approval is granted by Legislation Delta for Drug X, Legislation Delta follows the normal process for Drug X."
      },
      "(¬(A31 → ¬A32) → A33)": {
        "formal": "(¬(A31 → ¬A32) → A33)",
        "prover9": "(-(A31 -> -A32) -> A33)",
        "prover9_expression": "(-(conflicting_status(drug_x, region_alpha) -> -approved_status(drug_x, region_alpha)) -> resolved_status(drug_x, region_alpha))",
        "natural": "In the event that it is not true that conflicting status of Drug X in Region Alpha implies no approved status, then Drug X has resolved status in Region Alpha."
      },
      "(¬(A4 → (A3 → G)) → A21)": {
        "formal": "(¬(A4 → (A3 → G)) → A21)",
        "prover9": "(-(A4 -> (A3 -> G)) -> A21)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> regulatory_waiver(legislation_delta, drug_x))",
        "natural": "Should the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards be false, then Legislation Delta grants a regulatory waiver for Drug X."
      },
      "(¬(A4 → (A3 → G)) → A5)": {
        "formal": "(¬(A4 → (A3 → G)) → A5)",
        "prover9": "(-(A4 -> (A3 -> G)) -> A5)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> market_access(drug_x, region_alpha))",
        "natural": "If it is not the case that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Drug X has market access in Region Alpha."
      },
      "(¬(A4 → (A3 → G)) → A6)": {
        "formal": "(¬(A4 → (A3 → G)) → A6)",
        "prover9": "(-(A4 -> (A3 -> G)) -> A6)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> clinical_trial(drug_x, organization_gamma))",
        "natural": "Provided that the implication from compliance of Organization Gamma with Legislation Delta to testing resulting in Drug X meeting standards is false, Drug X is in clinical trial with Organization Gamma."
      },
      "(¬(A4 → (A3 → G)) → ¬A21)": {
        "formal": "(¬(A4 → (A3 → G)) → ¬A21)",
        "prover9": "(-(A4 -> (A3 -> G)) -> -A21)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -regulatory_waiver(legislation_delta, drug_x))",
        "natural": "In the case that it is not true that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X."
      },
      "(¬(A4 → (A3 → G)) → ¬A5)": {
        "formal": "(¬(A4 → (A3 → G)) → ¬A5)",
        "prover9": "(-(A4 -> (A3 -> G)) -> -A5)",
        "prover9_expression": "(-(compliant(organization_gamma, legislation_delta) -> (tested(drug_x, organization_gamma) -> meets_standards(drug_x, organization_gamma))) -> -market_access(drug_x, region_alpha))",
        "natural": "Whenever the condition that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards is false, Drug X does not have market access in Region Alpha."
      },
      "(¬(A9 ∨ G) → A10)": {
        "formal": "(¬(A9 ∨ G) → A10)",
        "prover9": "(-(A9 | G) -> A10)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> standard_approval(drug_x, region_alpha))",
        "natural": "If neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X has standard approval in Region Alpha."
      },
      "(¬(A9 ∨ G) → A26)": {
        "formal": "(¬(A9 ∨ G) → A26)",
        "prover9": "(-(A9 | G) -> A26)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> preliminary_approval(drug_x, region_alpha))",
        "natural": "Provided that Drug X is not authorized for emergency use in Region Alpha and does not meet the standards of Organization Gamma, Drug X has preliminary approval in Region Alpha."
      },
      "(¬(A9 ∨ G) → A27)": {
        "formal": "(¬(A9 ∨ G) → A27)",
        "prover9": "(-(A9 | G) -> A27)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> interim_approval(drug_x, region_alpha))",
        "natural": "In the event that Drug X lacks emergency use authorization in Region Alpha and fails to meet the standards of Organization Gamma, Drug X has interim approval in Region Alpha."
      },
      "(¬(A9 ∨ G) → A28)": {
        "formal": "(¬(A9 ∨ G) → A28)",
        "prover9": "(-(A9 | G) -> A28)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> provisional_approval(drug_x, region_alpha))",
        "natural": "Should Drug X not be authorized for emergency use in Region Alpha and not meet the standards of Organization Gamma, then Drug X has provisional approval in Region Alpha."
      },
      "(¬(A9 ∨ G) → ¬A10)": {
        "formal": "(¬(A9 ∨ G) → ¬A10)",
        "prover9": "(-(A9 | G) -> -A10)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -standard_approval(drug_x, region_alpha))",
        "natural": "Given that Drug X is not authorized for emergency use in Region Alpha and does not meet the standards of Organization Gamma, Drug X does not have standard approval in Region Alpha."
      },
      "(¬(A9 ∨ G) → ¬A26)": {
        "formal": "(¬(A9 ∨ G) → ¬A26)",
        "prover9": "(-(A9 | G) -> -A26)",
        "prover9_expression": "(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> -preliminary_approval(drug_x, region_alpha))",
        "natural": "If it is not the case that Drug X is authorized for emergency use in Region Alpha or meets the standards of Organization Gamma, then Drug X does not have preliminary approval in Region Alpha."
      },
      "(¬(¬(A9 ∨ G) → A28) → A29)": {
        "formal": "(¬(¬(A9 ∨ G) → A28) → A29)",
        "prover9": "(-(-(A9 | G) -> A28) -> A29)",
        "prover9_expression": "(-(-(emergency_use(drug_x, region_alpha) | meets_standards(drug_x, organization_gamma)) -> provisional_approval(drug_x, region_alpha)) -> final_approval(drug_x, region_alpha))",
        "natural": "Provided that the failure of lacking emergency use authorization or meeting standards to imply provisional approval holds, then Drug X has final approval in Region Alpha."
      },
      "(¬(¬G → A16) → A17)": {
        "formal": "(¬(¬G → A16) → A17)",
        "prover9": "(-(-G -> A16) -> A17)",
        "prover9_expression": "(-(-meets_standards(drug_x, organization_gamma) -> conditional_approval(drug_x, region_alpha)) -> full_approval(drug_x, region_alpha))",
        "natural": "In the case that the condition of not meeting standards not implying conditional approval is met, then Drug X has full approval in Region Alpha."
      },
      "(¬(¬G → ¬A1) → A18)": {
        "formal": "(¬(¬G → ¬A1) → A18)",
        "prover9": "(-(-G -> -A1) -> A18)",
        "prover9_expression": "(-(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)) -> manufacturing_approved(organization_gamma, drug_x))",
        "natural": "Should the scenario where not meeting standards does not lead to lack of approval occur, then Organization Gamma has manufacturing approval for Drug X."
      },
      "(¬(¬G → ¬A1) → A19)": {
        "formal": "(¬(¬G → ¬A1) → A19)",
        "prover9": "(-(-G -> -A1) -> A19)",
        "prover9_expression": "(-(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha)) -> production_certified(organization_gamma, drug_x))",
        "natural": "If it is not true that not meeting the standards implies no approval for Drug X, then Organization Gamma has production certification for Drug X."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-meets_standards(drug_x, organization_gamma) -> approved(drug_x, region_alpha))",
        "natural": "Whenever Drug X does not meet the standards of Organization Gamma, Drug X is approved in Region Alpha."
      },
      "(¬G → A16)": {
        "formal": "(¬G → A16)",
        "prover9": "(-G -> A16)",
        "prover9_expression": "(-meets_standards(drug_x, organization_gamma) -> conditional_approval(drug_x, region_alpha))",
        "natural": "Provided that Drug X does not meet the standards of Organization Gamma, Drug X has conditional approval in Region Alpha."
      },
      "(¬G → A30)": {
        "formal": "(¬G → A30)",
        "prover9": "(-G -> A30)",
        "prover9_expression": "(-meets_standards(drug_x, organization_gamma) -> temporary_approval(drug_x, region_alpha))",
        "natural": "In the event that Drug X does not meet the standards of Organization Gamma, Drug X has temporary approval in Region Alpha."
      },
      "(¬G → ¬A1)": {
        "formal": "(¬G → ¬A1)",
        "prover9": "(-G -> -A1)",
        "prover9_expression": "(-meets_standards(drug_x, organization_gamma) -> -approved(drug_x, region_alpha))",
        "natural": "Should Drug X not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha."
      },
      "A2": {
        "formal": "A2",
        "prover9": "A2",
        "prover9_expression": "banned(drug_x, region_beta)",
        "natural": "Drug X is banned in Region Beta."
      },
      "A3": {
        "formal": "A3",
        "prover9": "A3",
        "prover9_expression": "tested(drug_x, organization_gamma)",
        "natural": "Drug X is tested by Organization Gamma."
      },
      "A4": {
        "formal": "A4",
        "prover9": "A4",
        "prover9_expression": "compliant(organization_gamma, legislation_delta)",
        "natural": "Organization Gamma is compliant with Legislation Delta."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "meets_standards(drug_x, organization_gamma)",
        "natural": "Drug X meets the standards of Organization Gamma."
      },
      "¬A15": {
        "formal": "¬A15",
        "prover9": "-A15",
        "prover9_expression": "-traditional_pathway(legislation_delta, drug_x)",
        "natural": "It is not the case that Legislation Delta follows the traditional pathway for Drug X."
      },
      "¬A16": {
        "formal": "¬A16",
        "prover9": "-A16",
        "prover9_expression": "-conditional_approval(drug_x, region_alpha)",
        "natural": "Drug X does not have conditional approval in Region Alpha."
      },
      "¬A17": {
        "formal": "¬A17",
        "prover9": "-A17",
        "prover9_expression": "-full_approval(drug_x, region_alpha)",
        "natural": "Drug X does not have full approval in Region Alpha."
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-manufacturing_approved(organization_gamma, drug_x)",
        "natural": "Organization Gamma does not have manufacturing approval for Drug X."
      },
      "¬A24": {
        "formal": "¬A24",
        "prover9": "-A24",
        "prover9_expression": "-standard_procedure(legislation_delta, drug_x)",
        "natural": "Legislation Delta does not follow standard procedure for Drug X."
      },
      "¬A29": {
        "formal": "¬A29",
        "prover9": "-A29",
        "prover9_expression": "-final_approval(drug_x, region_alpha)",
        "natural": "Drug X does not have final approval in Region Alpha."
      },
      "¬A31": {
        "formal": "¬A31",
        "prover9": "-A31",
        "prover9_expression": "-conflicting_status(drug_x, region_alpha)",
        "natural": "Drug X does not have conflicting status in Region Alpha."
      },
      "¬A33": {
        "formal": "¬A33",
        "prover9": "-A33",
        "prover9_expression": "-resolved_status(drug_x, region_alpha)",
        "natural": "Drug X does not have resolved status in Region Alpha."
      },
      "¬A9": {
        "formal": "¬A9",
        "prover9": "-A9",
        "prover9_expression": "-emergency_use(drug_x, region_alpha)",
        "natural": "Drug X is not authorized for emergency use in Region Alpha."
      }
    }
  }
}